ORMP logo

Oramed Pharmaceuticals (ORMP)

Profile

Full Name

Oramed Pharmaceuticals Inc.

Ticker Symbol

ORMP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 1, 2007

Indexes

Not included

Website

http://www.oramed.com

Employees

13

Key Details

Price

$2.16(-1.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.48(-442.86% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.16
ORMP price is $2.16

30-Day Relative Volume

0.62
ORMP 30-day relative volume is 0.62

Price Performance

Price Today change

-1.82%
ORMP price is down -1.82% today

Price YTD change

-10.74%
ORMP price is down -10.74% since January 1st

Price 1-year change

-7.3%
ORMP price is down -7.3% year-on-year

Price 3-year change

-68.51%
ORMP price is down -68.51% over the past 3 years

Price Range

Price All-time high

$31.73
ORMP price is currently -93.19% below its historical high of $31.73

Price 3-year low

$1.67
ORMP price is currently +29.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$88.24M
ORMP market capitalization is $88.24 million

Market cap 3-year change

-66.65%
ORMP market capitalization is down -66.65% over the past 3 years

Market cap All-time high

$1.13B
ORMP market capitalization is currently -92.20% below its historical high of $1.13 billion

Market cap sector rank

47.04%
ORMP market capitalization is higher than 47.04% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.82%
ORMP shares outstanding is up +0.82% year-on-year

Shares Outstanding 3-Year Change

+5.93%
ORMP shares outstanding is up +5.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.59
ORMP beta is 0.59

200-day SMA

$2.36
ORMP price is currently -8.54% below its 200-day simple moving average

50-day SMA

$2.27
ORMP price is currently -4.73% below its 50-day simple moving average

RSI

48.42
ORMP 14-day relative strength index is 48.42

Volume

0.62
ORMP 30-day relative volume is 0.62

ATR

$0.13
ORMP average true range is $0.13

10-day Historical Volatility

54.28%
ORMP 10-day historical volatility is 54.28%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ORMP annual revenue value is unknown

Revenue Analysts estimate

$1.00M
ORMP annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ORMP annual revenue 1-year change is unknown

Revenue Sector rank

-
ORMP annual revenue is unknown

EPS

EPS

-$0.48
ORMP annual earnings per share is -$0.48

EPS Analysts estimate

-$0.26
ORMP annual earnings per share is currently +84.62% higher than the consensus analysts' forecast

EPS 1-year change

-442.86%
ORMP annual earnings per share is down -442.86% year-on-year

EPS Sector rank

69.42%
ORMP annual earnings per share is higher than 69.42% of companies in Healthcare sector

Profit

Gross profit

-
ORMP annual gross profit value is unknown

Gross margin

-
ORMP annual gross profit margin value is unknown

Operating profit

-$12.78M
ORMP annual operating income is -$12.78 million

Operating margin

-
ORMP annual operating profit margin value is unknown

Net income

-$19.06M
ORMP annual net profit is -$19.06 million

Net margin

-
ORMP annual net profit margin value is unknown

Expenses

Total expenses

$12.78M
ORMP annual total expenses is $12.78 million

Operating expenses

$12.78M
ORMP annual total operating expenses is $12.78 million

Cost of goods sold

-
ORMP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.46M
ORMP annual SGA is $6.46 million

Depreciation and amortization

$193.00K
ORMP annual depreciation & amortization is $193.00 thousand

Interest expense

$853.00K
ORMP annual interest expense is $853.00 thousand

Income tax

$3.18M
ORMP annual income tax is $3.18 million

EBIT & EBITDA

EBIT

-$15.07M
ORMP annual earnings before interest & taxes is -$15.07 million

EBITDA

-$14.87M
ORMP annual EBITDA is -$14.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$155.28M
ORMP annual total assets is $155.28 million

Non current assets

$12.06M
ORMP annual long term assets is $12.06 million

Current assets

$143.22M
ORMP annual total current assets is $143.22 million

Cash and cash equivalents

$54.42M
ORMP annual cash & cash equivalents is $54.42 million

Accounts receivable

-
ORMP annual accounts receivable value is unknown

Inventory

-
ORMP annual inventory value is unknown

Liabilities

Total liabilities

$9.93M
ORMP annual total liabilities is $9.93 million

Long term liabilities

$4.25M
ORMP annual total long term liabilities is $4.25 million

Current liabilities

$5.68M
ORMP annual total current liabilities is $5.68 million

Accounts payable

$789.00K
ORMP annual accounts payable is $789.00 thousand

Debt

Total debt

$372.00K
ORMP annual total debt is $372.00 thousand

Total debt 1-year change

-99.28%
ORMP annual total debt is down -99.28% year-on-year

Long term debt

$156.00K
ORMP annual long term debt is $156.00 thousand

Short term debt

$216.00K
ORMP annual short term debt is $216.00 thousand

Equity & Capital

Shareholders equity

$146.26M
ORMP annual stockholders equity is $146.26 million

Book value

$146.26M
ORMP annual book value is $146.26 million

Retained earnings

-$176.62M
ORMP annual retained earnings is -$176.62 million

Working capital

$137.54M
ORMP annual working capital is $137.54 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.41M
ORMP annual cash flow from operations is -$8.41 million

Cash from operations 1-year change

+18.29%
ORMP annual cash flow from operations is up +18.29% year-on-year

Cash from investing

$105.82M
ORMP annual cash flow from investing activities is $105.82 million

Cash from investing 1-year change

+244.88%
ORMP annual cash flow from investing activities is up +244.88% year-on-year

Cash from financing

-$52.04M
ORMP annual cash flow from financing activities is -$52.04 million

Cash from financing 1-year change

-200.11%
ORMP annual cash flow from financing activities is down -200.11% year-on-year

CAPEX

CAPEX

-
ORMP annual capital expenditures value is unknown

CAPEX 1-year change

-
ORMP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.43M
ORMP annual free cash flow is -$8.43 million

Free cash flow 1-year change

+20.09%
ORMP annual free cash flow is up +20.09% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ORMP annual gross profit margin value is unknown

Operating margin

-
ORMP annual operating profit margin value is unknown

Net margin

-
ORMP annual net profit margin value is unknown

ROA & ROE

ROA

-12.27%
ORMP annual return on assets is -12.27%

ROE

-13.03%
ORMP annual return on equity is -13.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ORMP price to earnings ratio value is unknown

PE ratio Sector rank

-
ORMP price to earnings ratio is unknown

PB Ratio

PB ratio

0.60
ORMP price to book ratio is 0.60

PB ratio Sector rank

33.2%
ORMP price to book ratio is higher than 33.2% of companies in Healthcare sector

PS Ratio

PS ratio

-
ORMP price to sales ratio value is unknown

PS ratio Sector rank

-
ORMP price to sales ratio is unknown

Enterprise value

Enterprise value

$34.19M
ORMP enterprise value is $34.19 million

Enterprise value Sector rank

36.66%
ORMP enterprise value is higher than 36.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

62.62
ORMP EV/EBITDA is 62.62

EV/EBITDA Sector rank

97.91%
ORMP EV/EBITDA is higher than 97.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

25.19
ORMP annual current ratio is 25.19

Quick ratio

-
ORMP annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ORMP annual debt to equity ratio is 0.00

Interest coverage ratio

-17.66
ORMP annual interest coverage ratio is -17.66

Risk & Stability

Piotroski F-Score

-
ORMP piotroski f-score value is unknown

Altman Z-Score

-
ORMP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Sep 9, 24 HC Wainwright & Co.
Neutral
May 20, 24 HC Wainwright & Co.
Neutral
May 17, 23 Canaccord Genuity
Hold
Jan 17, 23 HC Wainwright & Co.
Neutral
Jan 12, 23 Canaccord Genuity
Hold
May 16, 22 Aegis Capital
Buy
Feb 18, 22 Cantor Fitzgerald
Overweight
Nov 30, 21 HC Wainwright & Co.
Buy
Nov 29, 21 HC Wainwright & Co.
Buy
Nov 2, 21 Aegis Capital
Buy

Institutional Ownership

Similar stocks

XBIT logo
XBiotech (XBIT)
IMUX logo
Immunic (IMUX)
ZNTL logo
Zentalis Pharmaceuticals (ZNTL)
ANIX logo
Anixa Biosciences (ANIX)
NAUT logo
Nautilus Biotechnology (NAUT)
PLRX logo
Pliant Therapeutics (PLRX)
COYA logo
Coya Therapeutics (COYA)
MGRM logo
Monogram Orthopaedics (MGRM)
OPTN logo
OptiNose (OPTN)
  • What is the ticker symbol for Oramed Pharmaceuticals?
  • Does Oramed Pharmaceuticals pay dividends?
  • What sector is Oramed Pharmaceuticals in?
  • What industry is Oramed Pharmaceuticals in?
  • What country is Oramed Pharmaceuticals based in?
  • When did Oramed Pharmaceuticals go public?
  • Is Oramed Pharmaceuticals in the S&P 500?
  • Is Oramed Pharmaceuticals in the NASDAQ 100?
  • Is Oramed Pharmaceuticals in the Dow Jones?
  • When was Oramed Pharmaceuticals's last earnings report?
  • When does Oramed Pharmaceuticals report earnings?
  • Should I buy Oramed Pharmaceuticals stock now?

What is the ticker symbol for Oramed Pharmaceuticals?

The ticker symbol for Oramed Pharmaceuticals is NASDAQ:ORMP

Does Oramed Pharmaceuticals pay dividends?

No, Oramed Pharmaceuticals does not pay dividends

What sector is Oramed Pharmaceuticals in?

Oramed Pharmaceuticals is in the Healthcare sector

What industry is Oramed Pharmaceuticals in?

Oramed Pharmaceuticals is in the Biotechnology industry

What country is Oramed Pharmaceuticals based in?

Oramed Pharmaceuticals is headquartered in United States

When did Oramed Pharmaceuticals go public?

Oramed Pharmaceuticals's initial public offering (IPO) was on May 1, 2007

Is Oramed Pharmaceuticals in the S&P 500?

No, Oramed Pharmaceuticals is not included in the S&P 500 index

Is Oramed Pharmaceuticals in the NASDAQ 100?

No, Oramed Pharmaceuticals is not included in the NASDAQ 100 index

Is Oramed Pharmaceuticals in the Dow Jones?

No, Oramed Pharmaceuticals is not included in the Dow Jones index

When was Oramed Pharmaceuticals's last earnings report?

Oramed Pharmaceuticals's most recent earnings report was on Nov 7, 2024

When does Oramed Pharmaceuticals report earnings?

The next expected earnings date for Oramed Pharmaceuticals is May 9, 2025

Should I buy Oramed Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page